MDH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.085800E-01
Normal-vs-Stage2
4.801400E-01
Normal-vs-Stage3
3.923200E-01
Normal-vs-Stage4
6.622000E-01
Stage1-vs-Stage2
6.414000E-01
Stage1-vs-Stage3
4.712400E-01
Stage1-vs-Stage4
9.337400E-01
Stage2-vs-Stage3
3.827400E-01
Stage2-vs-Stage4
7.882800E-01
Stage3-vs-Stage4
4.641000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.854600E-01
Normal-vs-AfricanAmerican
2.937200E-01
Normal-vs-Asian
4.326200E-01
Caucasian-vs-AfricanAmerican
6.580000E-01
Caucasian-vs-Asian
4.968200E-01
AfricanAmerican-vs-Asian
9.466400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.272000E-01
Normal-vs-Female
5.966000E-01
Male-vs-Female
6.010600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.866800E-01
Normal-vs-Age(41-60Yrs)
6.465000E-01
Normal-vs-Age(61-80Yrs)
5.198200E-01
Normal-vs-Age(81-100Yrs)
7.121600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.993700E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.933400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.167400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.491900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.681600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.989400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.718800E-01
Normal-vs-Daily Drinker
3.100800E-01
Normal-vs-Weekly Drinker
2.966200E-01
Normal-vs-Occasional Drinker
9.159400E-01
Normal-vs-Social Drinker
9.218800E-01
Non Drinker-vs-Daily Drinker
7.515400E-01
Non Drinker-vs-Weekly Drinker
9.958200E-01
Non Drinker-vs-Occasional Drinker
1.634130E-02
Non Drinker-vs-Social Drinker
7.365900E-02
Daily Drinker-vs-Weekly Drinker
7.864000E-01
Daily Drinker-vs-Occasional Drinker
3.560100E-02
Daily Drinker-vs-Social Drinker
1.309430E-01
Weekly Drinker-vs-Occasional Drinker
4.190200E-02
Weekly Drinker-vs-Social Drinker
1.335810E-01
Occasional Drinker-vs-Social Drinker
7.167200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.826020E-01
Normal-vs-Grade 2
4.925800E-01
Normal-vs-Grade 3
4.945600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.810400E-01
Grade 1-vs-Grade 3
8.091200E-01
Grade 1-vs-Grade 4
1.826020E-01
Grade 2-vs-Grade 3
9.596400E-01
Grade 2-vs-Grade 4
4.925800E-01
Grade 3-vs-Grade 4
4.945600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.203800E-01
Normal-vs-NonDiabetic
5.163800E-01
Diabetic-vs-NonDiabetic
7.594400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.541000E-01
Normal-vs-NoPancreatitis
5.058600E-01
Pancreatitis-vs-NoPancreatitis
8.848600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.406600E-01
Normal-vs-N1
4.483200E-01
N0-vs-N1
8.117900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.469800E-01
Normal-vs-TP53-NonMutant
3.187000E-01
TP53-Mutant-vs-TP53-NonMutant
1.256960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
